JP Morgan Chase
KURA icon

JP Morgan Chase’s Kura Oncology KURA Stock Holding History

JP Morgan Chase’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-55,000
Closed -$1.8M – 6208
2020
Q4 		$1.8M Buy
+55,000
New +$1.93M ﹤0.01% 3554

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

JP Morgan Chase's KURA Position: Q2 2026 in Review

JP Morgan Chase increased its Kura Oncology (KURA) stake by 368% in Q2 2026, buying an estimated $1.82M and bringing the position to 245,920 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3965.

JP Morgan Chase first reported a position in KURA in Q3 2017 and has held it in 36 quarters since. The position peaked at $10.3M in Q2 2022. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • JP Morgan Chase held 245,920 shares of Kura Oncology worth $2.7M as of Q2 2026.
  • JP Morgan Chase bought 193,348 Kura Oncology shares in Q2 2026, an estimated $1.82M.
  • Kura Oncology made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3965 holding.
  • JP Morgan Chase first reported a position in Kura Oncology in Q3 2017 and has held it in 36 quarters since.
  • JP Morgan Chase's Kura Oncology position peaked at $10.3M in Q2 2022.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.